Reduced expression of autophagy markers correlates with high-risk human papillomavirus infection in human cervical squamous cell carcinoma

Oncology Letters

Volumn 8, Issue 4, 2014, Pages 1492-1498

  Wang, Hua Yi ^a   Yang, Gui Fang ^b   Huang, Yan Hua ^c   Huang, Qi Wen ^a   Gao, Jun ^c   Zhao, Xian Da ^d   Huang, Li Ming ^b   Chen, Hong Lei ^d  

^a Second Hospital of Jingzhou   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Department of Molecular Pathology   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

Autophagy; Beclin 1; Cervical cancer; Human papilloma virus; Light chain 3B; Quantum dots

Indexed keywords

BECLIN 1; MICROTUBULE ASSOCIATED PROTEINS 1A/1B LIGHT CHAIN 3B; PEPTIDES AND PROTEINS; QUANTUM DOT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPHAGY; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CERVICAL SQUAMOUS CELL CARCINOMA; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE HISTOCHEMISTRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOFLUORESCENCE HISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; VIRUS CELL INTERACTION;

EID: 84923068288     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2417     Document Type: Article

References (38)

1. Pandey S, Mishra M and Chandrawati: Human papillomavirus screening in north Indian women. Asian Pac J Cancer Prev 13: 2643-2646, 2012.
2. Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
3. Li J, Kang LN and Qiao YL: Review of the cervical cancer disease burden in mainland China. Asian Pac J Cancer Prev 12: 1149-1153, 2011.
4. Muñoz N: Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19: 1-5, 2000.
5. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350, 2002.
6. Nakatogawa H, Suzuki K, Kamada Y and Ohsumi Y: Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 10: 458-467, 2009.
7. Liu JJ, Lin M, Yu JY, Liu B and Bao JK: Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 300: 105-114, 2011.
8. Janku F, McConkey DJ, Hong DS and Kurzrock R: Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 8: 528-539, 2011.
9. Mathew R and White E: Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev 21: 113-119, 2011.
10. Mizushima N: The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ 12 (Suppl 2): S1535-S1541, 2005.
11. Chen HL, Peng J, Zhu XB, et al: Detection of EBV in nasopharyngeal carcinoma by quantum dot fluorescent in situ hybridization. Exp Mol Pathol 89: 367-371, 2010.
12. Eskelinen EL and Saftig P: Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 1793: 664-673, 2009.
13. Miracco C, Cevenini G, Franchi A, et al: Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 41: 503-512, 2010.
14. Zhang YH, Wu YL, Tashiro S, Onodera S and Ikejima T: Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells. Acta Pharmacol Sin 32: 1266-1275, 2011.
15. Wang ZH, Xu L, Wang Y, Cao MQ, Li L and Bai T: Clinicopathologic correlations between human papillomavirus 16 infection and Beclin 1 expression in human cervical cancer. Int J Gynecol Pathol 30: 400-406, 2011.
16. Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105: 103-104, 2009.
17. Li M, Chen H, Diao L, Zhang Y, Xia C and Yang F: Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori 96: 734-743, 2010.
18. Chen H, Xue J, Zhang Y, Zhu X, Gao J and Yu B: Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol 40: 261-268, 2009.
19. He Y, Zhao X, Gao J, et al: Quantum dots-based immunofluorescent imaging of stromal fibroblasts caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. Int J Mol Sci 13: 13764-13780, 2012.
20. Li ZH, Peng J and Chen HL: Bioconjugated quantum dots as fluorescent probes for biomedical imaging. J Nanosci Nanotechnol 11: 7521-7536, 2011.
21. Karpathiou G, Sivridis E, Koukourakis MI, et al: Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest 140: 127-134, 2011.
22. Sivridis E, Koukourakis MI, Zois CE, et al: LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol 176: 2477-2489, 2010.
23. Yoshioka A, Miyata H, Doki Y, et al: LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int J Oncol 33: 461-468, 2008.
24. Liang XH, Jackson S, Seaman M, et al: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676, 1999.
25. Jiang ZF, Shao LJ, Wang WM, Yan XB and Liu RY: Decreased expression of Beclin-1 and LC3 in human lung cancer. Mol Biol Rep 39: 259-267, 2012.
26. Nicotra G, Mercalli F, Peracchio C, et al: Autophagy-active beclin-1 correlates with favourable clinical outcome in nonHodgkin lymphomas. Mod Pathol 23: 937-950, 2010.
27. Geng QR, Xu DZ, He LJ, et al: Beclin-1 expression is a significant predictor of survival in patients with lymph node-positive gastric cancer. PLoS One 7: e45968, 2012.
28. Zhu W, Pan X, Li F, Zhang Y and Lu X: Expression of Beclin 1 and LC3 in FIGO stage I-II cervical squamous cell carcinoma and relationship to survival. Tumour Biol 33: 1653-1659, 2012.
29. Fujii S, Mitsunaga S, Yamazaki M, et al: Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99: 1813-1819, 2008.
30. Deretic V and Levine B: Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5: 527-549, 2009.
31. Jordan TX and Randall G: Manipulation or capitulation: virus interactions with autophagy. Microbes Infect 14: 126-139, 2012.
32. Griffin LM, Cicchini L and Pyeon D: Human papillomavirus infection is inhibited by host autophagy in primary human keratinocytes. Virology 437: 12-19, 2013.
33. Ishii Y: Electron microscopic visualization of autophagosomes induced by infection of human papillomavirus pseudovirions. Biochem Biophys Res Commun 433: 385-389, 2013.
34. Spangle JM and Münger K: The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 84: 9398-9407, 2010.
35. Clarke MA, Wentzensen N, Mirabello L, et al: Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiol Biomarkers Prev 21: 2125-2137, 2012.
36. Surviladze Z, Sterk RT, DeHaro SA and Ozbun MA: Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol 87: 2508-2517, 2013.
37. Chen TC, Hung YC, Lin TY, et al: Human papillomavirus infection and expression of ATPase family AAA domain containing 3A, a novel anti-autophagy factor, in uterine cervical cancer. Int J Mol Med 28: 689-696, 2011.
38. Feng W, Duan X, Liu J, Xiao J and Brown RE: Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions. Int J Clin Exp Pathol 2: 249-260, 2009.